Associate Professor, Pediatrics, Perelman School of Medicine

Pediatric Hematology & Oncology

Dr. Leslie J. Raffini practices Pediatric Hematology & Oncology. She went to medical school at University of Wisconsin School of Medicine and Public Health. Leslie Raffini is a published doctor as well. She has 39 publications published. The latest was: Pleiotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication.

Publications

---

• Endovascular Thrombolysis in the Management of Iliofemoral Thrombosis in Children: A Multi-Institutional Experience.
• Comparison of 3 Postthrombotic Syndrome Assessment Scales Demonstrates Significant Variability in Children and Adolescents With Deep Vein Thrombosis.
• A guide to the use of anticoagulant drugs in children.
• Outcomes using a clinical practice pathway for the management of pulse loss following pediatric cardiac catheterization.
• Rituximab for treatment of inhibitors in haemophilia A. A Phase II Study.
• Safety of prophylactic antiCoagulation at a pediatric hospital.
• Off-Label Recombinant Factor VIIa Use and Thrombosis in Children: A Multi-Center Cohort Study.
• Varied opinions on thrombolysis for venous thromboembolism in infants and children: findings from a survey of pediatric hematology-oncology specialists.
• The clinical management of Hemophilia and head trauma: a survey of current clinical practice among pediatric hematology/oncology physicians.
• Incidence of bleeding complications in pediatric patients with type 1 von Willebrand Disease undergoing adenotonsillar procedures.
• Headache in children with Sickle cell disease: prevalence and associated factors.
• Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association?
• Prolongation of the prothrombin time and activated partial thromboplastin time in children with Sickle cell disease.
• Cystic fibrosis as a risk factor for recurrent venous Thrombosis at a pediatric tertiary care hospital.
• Neutropenia following IVIG therapy in pediatric patients with Immune-mediated thrombocytopenia.
• Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of M...
• Thromboelastography of patients after fontan compared with healthy children.
• Thrombolysis for intravascular Thrombosis in neonates and children.
• Thrombophilia in children: who to test, how, when, and why?
• Evaluation of pulmonary embolism in a pediatric population with high clinical suspicion.
• A prospective observational study of IVC filters in pediatric patients.
• Utility of computed tomography of the head following head trauma in boys with haemophilia.
• Successful haploidentical bone marrow transplantation in a patient with reticular dysgenesis: three-year follow-up.
• Significant increase in clopidogrel use across U.S. children's hospitals.
• Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States.
• Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous Thrombosis in neonates and children: a systematic review and meta-analysis of observ...
• Diagnosis of inherited thrombophilia in pediatrics.
• Age-dependent effects of RPE65 gene therapy for Leber''s congenital amaurosis: a phase 1 dose-escalation trial.
• Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.
• Testing children for inherited thrombophilia: more questions than answers.
• Subgaleal hematoma from hair braiding leads to the diagnosis of von Willebrand Disease.
• May-Thurner syndrome (iliac Vein compression) and thrombosis in adolescents.
• Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effect.
• Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres.
• Argatroban therapy in pediatric patients requiring nonheparin antiCoagulation: an open-label, safety, efficacy, and pharmacokinetic study.
• Thromboprophylaxis in a pediatric hospital: a patient-safety and quality-improvement initiative.
• Pleiotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication.
• Modern management of haemophilic arthropathy.

Schools

---

• University Of Wisconsin Medical School

• Children39s Hospital Philadelphia

• Johns Hopkins University School Med

Procedures Preformed

---

• Plasmapheresis

Conditions Treated

---

• Anemia
• Coagulation Disorders (incl. Hemophilia)
• Deep Vein Thrombosis (DVT)
• Hypercoagulable State
• View All

Doctors Specialties

---

• Pediatric Hematology
• Oncology

Accepted Insurances

---

Education

---

• Children's Hospital of Philadelphia
• Johns Hopkins University
• University of Wisconsin School of Medicine and Public Health

Hospital

---

• Hospital of the University of Pennsylvania
• Pennsylvania Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Julie W. Stern, MD This Doctor is OpenDoctor Recommended.
	Dr. Rafat Ahmed, MD This Doctor is OpenDoctor Recommended.
	Dr. Marie Stuart, MD This Doctor is OpenDoctor Recommended.
	Dr. Haewon C. Kim, MD This Doctor is OpenDoctor Recommended.
	Dr. Stella T. Chou, MD This Doctor is OpenDoctor Recommended.
	Dr. Carolyn A. Felix, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Garrett M. Brodeur, MD This Doctor is OpenDoctor Recommended.
	Dr. Frank M. Balis, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jennifer Eng, MD This Doctor is OpenDoctor Recommended.
	Dr. Ayman Samkari, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog